Compare DERM & ISPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DERM | ISPR |
|---|---|---|
| Founded | 2014 | 2010 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Medicinal Chemicals and Botanical Products |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 210.0M | 175.8M |
| IPO Year | 2021 | 2023 |
| Metric | DERM | ISPR |
|---|---|---|
| Price | $8.73 | $3.07 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 1 |
| Target Price | ★ $12.67 | $7.50 |
| AVG Volume (30 Days) | ★ 143.6K | 40.6K |
| Earning Date | 11-12-2025 | 02-09-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $59,399,000.00 | ★ $118,506,875.00 |
| Revenue This Year | $17.48 | $11.60 |
| Revenue Next Year | $55.83 | $40.79 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 2.82 | N/A |
| 52 Week Low | $3.63 | $1.44 |
| 52 Week High | $9.56 | $4.98 |
| Indicator | DERM | ISPR |
|---|---|---|
| Relative Strength Index (RSI) | 59.80 | 57.66 |
| Support Level | $7.66 | $2.92 |
| Resistance Level | $9.00 | $3.30 |
| Average True Range (ATR) | 0.55 | 0.32 |
| MACD | 0.17 | 0.03 |
| Stochastic Oscillator | 69.63 | 68.04 |
Journey Medical Corp is a commercial stage pharmaceutical company focused on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions. The company's current product portfolio includes eight FDA-approved prescription drugs for dermatological conditions that are marketed in the U.S. Some of the group's products are Qbrexza, Accutane, Amzeeq, Exelderm and others.
Ispire Technology Inc is engaged in the research and development, design, commercialization, sales, marketing, and distribution of branded e-cigarettes and cannabis vaping products. The company sells its cannabis vaping products in the United States, Europe, Canada, and South Africa. Geographically, the company generates the majority of its revenue from Europe.